Mark Simmons

What is glycerol? Glycerol, also known as glycerin, is a colorless, odorless, and sweet-tasting viscous liquid that is hygroscopic and soluble in water. It is a simple polyol compound, consisting of three carbon atoms, each attached to a hydroxyl group (–OH). Glycerol is a byproduct of the soap-making process and the biodiesel production process, and it is widely used inRead more

When it comes to assay development and manufacturing, choosing the right Contract Development and Manufacturing Organisation (CDMO) is a critical decision that can significantly impact the success of your project. A CDMO’s expertise, capabilities, and approach can influence not only the quality of the final product but also the speed to market and regulatory compliance. Here are 10 key considerations

Read more

Lyophilizing critical reagents within diagnostic microfluidic cartridges can improve assay accessibility, increase shelf life and obviate the need for cold chain logistics. Moreover, when done so combining modern single-dose technologies and pick and place automated assembly, the process can also significantly reduce the cost-per-test of near-patient diagnostics. In this blog we examine the process in detail, and outline the advantagesRead more

Taking an assay from development to commercial scale manufacture is a complex process. Can the formulation be stabilised? Do you have the regulatory approval? And not least, how do you plan for fluctuations in demand? Unless you plan for assay scale up at the design stage, it’s quite common to find that what works in development does not transfer smoothly

Read more

Deeside, Wales 9, May 2024: Biofortuna Limited, the specialist laboratory services and CDMO, has completed the acquisition of Cryoniss Ltd, underlining its commitment to support life-changing research and development across the global biotech and life sciences sector. The acquisition of Cryoniss brings expertise and infrastructure in temperature-controlled biological sample storage, strengthening Biofortuna’s existing stability storage capability and accelerating the growth

Read more

We would like to extend a big Biofortuna welcome to Corinne Niger and Sarah Sadler as they become the latest additions to our European sales team. Corinne joins us from a similar role at Oxford Nanopore and has extensive experience in sales development and project scientist roles. Sarah arrives from LGC Biosearch Technologies having previously been at Meridian Bioscience. Together

Read more

We are delighted to share the news that our custom lyo bead Development and Manufacturing service has been shortlisted for the 2023 Bionow awards in the category of Technical Service of the Year. Now in their 22nd year, the regional Bionow awards celebrate the innovation and impact of the Life Sciences sector. A panel of judges reviewed detailed case studies

Read more

It is estimated that 33% of cell lines used in research are misidentified or contaminated. Therefore, routine testing is fundamental. Cell line authentication is a crucial step in scientific research, especially in fields such as cell biology, genetics, and biomedical research. According to current research and best practice guidelines, cell line testing is recommended: Before submitting a paper for reviewRead more

Download our application note to see how the precision and consistency of lyophilised beads is retained when manufactured at scale.

If you have always manufactured your in-vitro diagnostic (IVD) assays in-house, it’s tempting to stick with what is tried and tested. After all, it has worked up until now, and in theory manufacturing in-house should result in the seamless integration of development, validation, regulatory submission, and subsequent large-scale output. And if all those processes are managed in one place, then

Read more